Aspen secures game-changing HIV medicine

Alimatravir is in late-stage clinical trials and adds, once registered and approved, another weapon to South Africa’s arsenal against high infection rates

Aspen secures game-changing HIV  medicine
Alimatravir is in late-stage clinical trials and adds, once registered and approved, another weapon to South Africa’s arsenal against high infection rates